Reporter October 2023

October 17, 2023

Vanderbilt-Ingram Cancer Center earns NCI Merit Award

Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.

By Tom Wilemon
October 17, 2023

Tirzepatide trial shows additional 21.1% weight loss following intensive lifestyle intervention

A Vanderbilt clinical trial evaluating the injectable prescription medication tirzepatide, showed an additional 21.1% weight loss after intensive lifestyle intervention in adults with obesity or who were overweight with weight-related comorbidities, excluding Type 2 diabetes.

By Jill Clendening
Wesley Self, MD, MPH
October 17, 2023

How biostatistics saves lives: the Vanderbilt experience

Biostatisticians at VUMC have played a pivotal role in the redesign of clinical trials that rigorously and rapidly determine the effectiveness of life-saving treatments for acutely ill patients.

By Bill Snyder
October 16, 2023

ICU antibiotics may be safe for kidneys

A Vanderbilt study found that two antibiotics thought to cause kidney failure in ICU patients with a severe bacterial infection, especially when combined with another antibiotic, may be safer for the kidneys than previously reported.

By Craig Boerner
x-ray of stomach
October 12, 2023

Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4

A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.

By Tom Wilemon
1 2 3